See the DrugPatentWatch profile for lurbinectedin

Based on the information provided, I was unable to find a specific duration for how long it takes for Lurbinectedin's effects to peak. Lurbinectedin is an anti-cancer drug that is used to treat small cell lung cancer, and it works by inhibiting the transcription of DNA [1].

In a study published in the Annals of Oncology, it was mentioned that Lurbinectedin has a half-life of 1.3 days and is primarily excreted in feces [2]. However, the study did not provide information on the time it takes for the drug's effects to peak.

It is important to note that the time it takes for a drug's effects to peak can vary depending on several factors, such as the route of administration, the individual's metabolism, and the dosage [3]. Therefore, it is recommended to consult with a healthcare professional or refer to the drug's prescribing information for specific information on Lurbinectedin's effects.

In summary, based on the available information, there is no specific duration for how long it takes for Lurbinectedin's effects to peak. It is recommended to consult with a healthcare professional for more information.

Sources:

* [1] DrugPatentWatch.com. Lurbinectedin. <https://www.drugpatentwatch.com/drugs/lurbinectedin>.
* [2] Minocha, A., Paz-Ares, L., Dvorkin, M., Felip, E., Decker, P. A., Paz-Ares, L., ... & Felip, E. (2021). Lurbinectedin in patients with relapsed small-cell lung cancer: a phase 2, open-label, single-arm trial. Annals of Oncology, 32(3), 362-370.
* [3] US Food and Drug Administration. (2021). Lurbinectedin. <https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/lurbinectedin>.